Table 2 Multivariable model for predicting CDH survival.
Patient Level Characteristics | OR 95% CI | p |
|---|---|---|
N (%) | ||
Median GA (weeks, 25–75th %ile) | 1.09 (1.02, 1.16) | 0.008 |
Female Sex (N, %) | 0.67 (0.51, 0.89) | 0.006 |
SGA (n, %) | 0.65 (0.43, 0.98) | 0.039 |
5 min Apgar < 3 (n, %) | 0.47 (0.27, 0.83) | 0.009 |
Any BSI (n, %) | 0.36 (0.25, 0.5) | <0.001 |
Birth year | ||
2010–2013 | referent | |
2014–2016 | 0.93 (0.63, 1.38) | 0.716 |
2017–2019 | 1.73 (1.15, 2.62) | 0.009 |
2020–2023 | 1.52 (1, 2.32) | 0.051 |
Antenatal diagnosis (n, %) | 0.63 (0.43, 0.94) | 0.022 |
Pre-repair thoracostomy tube (n, %) | 0.46 (0.29, 0.74) | 0.001 |
Congenital Heart Disease | ||
None | referent | |
ASD/VSD | 0.83 (0.58, 1.2) | 0.322 |
Other CHD | 0.29 (0.16,0.5) | <0.001 |
Lowest pH in first 12 h after admission | ||
<7.0 | referent | |
7.0–7.19 | 1.84 (1.19, 2.83) | 0.006 |
7.2–7.29 | 3.75 (2.33, 6.03) | <0.001 |
7.3–7.45 | 4.96 (2.97, 8.28) | <0.001 |
>7.45+ | 5.8 (2.1, 16.03) | <0.001 |
Liver Position in Thorax (n, %) | 0.5 (0.36, 0.7) | <0.001 |
Primary repair (n, %) | 2.36 (1.63, 3.41) | <0.001 |
Genetic Diagnoses | 0.46 (0.23, 0.9) | 0.024 |
Kidney Failure | 0.06 (0.04, 0.11) | <0.001 |
